Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-κB signaling

被引:120
作者
Rouet-Benzineb, R
Aparicio, T
Guilmeau, S
Pouzet, C
Descatoire, V
Buyse, M
Bado, A
机构
[1] Univ Paris 07, Lab Neuroendocrinol & Biol Cellulaire Digest, INSERM, U410, F-75860 Paris 18, France
[2] IFR 02, Serv Confocale, F-75860 Paris 18, France
[3] IFR 02, Serv Cytometrie Flux Digest, F-75860 Paris 18, France
关键词
D O I
10.1074/jbc.M312999200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study shows that leptin induced a rapid phosphorylation of p42/44 mitogen-activated protein kinase, an enhancement of both NF-kappaB DNA binding and transcriptional activities, and a concentration-dependent increase of HT-29 cell proliferation. These effects are consistent with the presence of leptin receptors on cell membranes. The leptin induction of cell growth was associated with an increase of cell population in S and G(2)/M phase compared with control cells found in G(0)/G(1) phase of the cell cycle. Moreover, cyclin D1 immunoreactivity was enhanced in leptin-treated HT-29 cells and this increase was essentially associated with cell population in G(0)/G(1) phase. On the other hand, we observed that sodium butyrate inhibited cell proliferation by blocking HT-29 cells in G(0)/G(1) phase of the cell cycle. Interestingly, at physiological concentration, leptin prevented sodium butyrate-induced morphological nucleus changes, DNA laddering and suppressed butyrate-induced cell cycle arrest. This anti-apoptotic effect of leptin was associated with HT-29 cell proliferation and activation NF-kappaB pathways. However, the phosphorylation of p42/44 MAP kinase in response to leptin was reduced in butyrate-treated cells. These data demonstrated that leptin is a potent mitogenic factor for intestinal epithelial cells through the MAP kinase and NF-kappaB pathways. They also showed, for the first time, that leptin promotes colon cancer HT-29 cell survival upon butyrate challenge by counteracting the apoptotic programs initiated by this short chain fatty acid probably through the NF-kappaB pathways. Although further studies are required to unravel the precise mechanism, these data may have significance in the pathogenesis of colorectal cancer and ulcerative colitis diseases.
引用
收藏
页码:16495 / 16502
页数:8
相关论文
共 43 条
[11]   Resistance to IP leptin-induced adipose apoptosis caused by high-fat diet in mice [J].
Della-Fera, MA ;
Li, CL ;
Baile, CA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 303 (04) :1053-1057
[12]   INDEPENDENT MODES OF TRANSCRIPTIONAL ACTIVATION BY THE P50-SUBUNIT AND P65-SUBUNIT OF NF-KAPPA-B [J].
FUJITA, T ;
NOLAN, GP ;
GHOSH, S ;
BALTIMORE, D .
GENES & DEVELOPMENT, 1992, 6 (05) :775-787
[13]   Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells [J].
Gainsford, T ;
Willson, TA ;
Metcalf, D ;
Handman, E ;
McFarlane, C ;
Ng, A ;
Nicola, NA ;
Alexander, WS ;
Hilton, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) :14564-14568
[14]   NF-κB and rel proteins:: Evolutionarily conserved mediators of immune responses [J].
Ghosh, S ;
May, MJ ;
Kopp, EB .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :225-260
[15]  
Guttridge DC, 1999, MOL CELL BIOL, V19, P5785
[16]   SODIUM-BUTYRATE INDUCES APOPTOSIS IN HUMAN COLONIC TUMOR-CELL LINES IN A P53-INDEPENDENT PATHWAY - IMPLICATIONS FOR THE POSSIBLE ROLE OF DIETARY FIBER IN THE PREVENTION OF LARGE-BOWEL CANCER [J].
HAGUE, A ;
MANNING, AM ;
HANLON, KA ;
HUSCHTSCHA, LI ;
HART, D ;
PARASKEVA, C .
INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (03) :498-505
[17]   The role of butyrate in human colonic epithelial cells: An energy source or inducer of differentiation and apoptosis? [J].
Hague, A ;
Butt, AJ ;
Paraskeva, C .
PROCEEDINGS OF THE NUTRITION SOCIETY, 1996, 55 (03) :937-943
[18]   Leptin is a growth factor for colonic epithelial cells [J].
Hardwick, JCH ;
Van den Brink, GR ;
Offerhaus, GJ ;
Van Deventer, SJH ;
Peppelenbosch, MP .
GASTROENTEROLOGY, 2001, 121 (01) :79-90
[19]  
HEERDT BG, 1994, CANCER RES, V54, P3288
[20]  
Hinz M, 1999, MOL CELL BIOL, V19, P2690